DCM
LIVN icon

DME Capital Management’s LivaNova LIVN Stock Holding History

DME Capital Management’s Portfolio LIVN Stock Details LIVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-603,549
Closed -$31.7M – 38
2024
Q3 		$31.7M Sell
603,549
-40,720
-6% -$2.02M 1.32% 20
2024
Q2 		$35.3M Sell
644,269
-688,535
-52% -$39.2M 1.73% 17
2024
Q1 		$74.6M Buy
+1,332,804
New +$69.3M 3.41% 9

Other funds holding LIVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

DME Capital Management's LIVN Position: Q4 2024 in Review

DME Capital Management sold out of LivaNova (LIVN) in Q4 2024, closing a stake of 603,549 shares — an estimated $31.7M sold.

DME Capital Management first reported a position in LIVN in Q1 2024 and held it in 3 quarters. The position peaked at $74.6M in Q1 2024. 256 funds tracked by Wall St. Rank hold LIVN as of Q4 2024.

  • DME Capital Management reported no remaining LivaNova position as of Q4 2024 after selling out during the quarter.
  • DME Capital Management sold 603,549 LivaNova shares in Q4 2024, an estimated $31.7M.
  • DME Capital Management first reported a position in LivaNova in Q1 2024 and held it in 3 quarters.
  • DME Capital Management's LivaNova position peaked at $74.6M in Q1 2024.
  • 256 funds tracked by Wall St. Rank held LivaNova as of Q4 2024.

Based on DME Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.